Document is current

Article History

Received: 20 June 2025

Accepted: 14 December 2025

First Online: 13 January 2026

Declarations

:

: S.d.P. and M.P.G. are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultant company specialized in the evaluation and assessment of healthcare interventions, which has received financial support from Takeda to develop the project. J.G. and F.J.G.D. declare no conflicts of interest. L.Q. received research grants from Instituto de Salud Carlos III – Ministry of Economy and Innovation (Spain), CIBERER, Fundació La Marató, GBS-CIDP Foundation International, and ArgenX. L.Q. received speaker or expert testimony honoraria from CSL Behring, Novartis, Sanofi-Genzyme, Merck, Annexon, Alnylam, ArgenX, Dianthus, LFB, Avilar Therapeutics, Lycia Therapeutics, Nuvig Therapeutics, Takeda, and Roche. L.Q. serves on the Clinical Trial Steering Committees for Sanofi Genzyme, ArgenX, and Takeda and is principal investigator for UCB’s CIDP01 trial and Sanofi’s Mobilize and Vitalize trials. All authors declare they have not received financial support for drafting or reviewing the present manuscript.

: All data supporting the findings of this study are available within the paper and its Supplementary Information.

: Not applicable. Ethical approval is considered unnecessary according to national regulations, as this is not a study but a literature review, and nonpatient level data are managed.

: Not applicable.

: Not applicable.

: The economic model used in this study is not publicly available to protect commercial-in-confidence information.

: S.d.P. and M.P.G. conceived the analysis, designed and programmed the decision analytical model. and drafted a results report. J.G., F.J.G., and L.Q. provided information about management of patients with CIDP in clinical practice. All authors reviewed the results report and participated in the data analysis and data interpretation. All authors had full access to the data and approved the final version of the manuscript for submission. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval for this version to be published.